medical innovations whose returns are earned worldwide. Because world returns drive innovation and innovation is central to … countries. This paper analyzes the unique positive and normative implications of these innovation-induced linkages across … countries when governments centrally price health care. Providing world returns to medical innovation under such central pricing …

models using annual U.S. time-series data on life expectancy, health expenditure, and medical innovation. Reliable annual … data are available for only one type of innovation - new drugs - but pharmaceutical R&D accounts for a significant fraction … innovation (in the form of new drug approvals) and expenditure on medical care (especially public expenditure) contributed to …

Pharmaceutical innovation policy involves managing a tradeoff between high prices for new products in the short … pharmaceuticals, suggesting low(er) price markets may have different dynamics with respect to innovation policy …

clinical trial design complexity. The results suggest that targeted regulatory innovation can shorten R&D periods without …

We investigate women's fertility, labor and marriage market responses to a health innovation that led to reductions in …

applied to the case of Computed Tomography (CT) Scanners, a revolutionary innovation in medical technology. The econometric … from innovation is used primarily to compute a social rate of return to R&D, to explore the interrelation between … innovation and diffusion, and to trace the time profile of benefits and costs, the latter suggesting the possible occurance of …

This paper studies how insurance coverage policies affect incentives for pharmaceutical innovation. In the United …